Selank vs Semax: A Research-Use Comparison of Two Russian Regulatory Neuropeptides
Two synthetic heptapeptides from the same Soviet-era programme, built on different parent molecules and studied along sharply divergent mechanistic lines.
Two synthetic heptapeptides from the same Soviet-era programme, built on different parent molecules and studied along sharply divergent mechanistic lines.
Two molecules lumped together as metabolic small molecules that share no target, no mechanism and no research question, set side by side.
Two compounds shelved side by side in metabolic catalogues turn out to share almost nothing at the molecular level — one switches an enzyme off, the other switches a receptor program on.
Two peptides forever paired in regenerative literature, yet chemically and mechanistically unrelated. What the preclinical record actually says, and why the choice is a research question, not a ranking.
Cookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.